Syndax Pharmaceuticals, Inc.SNDXNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+75.5%
5Y CAGR+51.5%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+75.5%/yr
vs +17.8%/yr prior
5Y CAGR
+51.5%/yr
Recent acceleration
Acceleration
+57.7pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
8x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $179.68M | +48.6% |
| 2024 | $120.88M | +80.6% |
| 2023 | $66.92M | +101.2% |
| 2022 | $33.26M | +31.8% |
| 2021 | $25.24M | +12.2% |
| 2020 | $22.50M | +40.1% |
| 2019 | $16.06M | -7.1% |
| 2018 | $17.29M | +9.0% |
| 2017 | $15.86M | +19.1% |
| 2016 | $13.32M | - |